Objective: Depressive symptoms are common among older adults with obesity and diabetes.
| INTRODUCTION
Depressive symptoms are common in patients with cardio-metabolic disorders, including diabetes, obesity, and metabolic syndrome. Recent studies showed that the presence of diabetes significantly increases the risk of depressive symptoms by 15% to 50% in the general population, and specifically among older adults. [1] [2] [3] Obesity and the diagnosis of metabolic syndrome are also associated with 40% to 50% higher risk of depression compared with subjects without metabolic syndrome. [4] [5] [6] The mechanisms by which cardio-metabolic disorders increase the risk of depression are not clear but may involve intrinsic biological changes and psychological responses to the disease. Recent studies showed that abnormalities in pro-inflammatory markers and cerebrovascular disease are related to depression in these patients. 7 In addition, our group showed in a recent study that awareness of the diagnosis of a diabetes and the related psychological impact play a major role in the development of depressive symptoms among the Hispanic population. 8 Insulin resistance is one of the key pathophysiological features of diabetes. 9 In addition, obese individuals show increased insulin resistance. 10 Preclinical and clinical studies also suggest that insulin resistance and the activation of intracellular signaling cascades related to the insulin action are associated with depression in young and older adults. [11] [12] [13] [14] As insulin resistance can be directly evaluated using the HOMA-IR (Homeostatic model assessment-insulin resistance) index, past studies investigated whether insulin resistance is associated with major depression in the general population. 15 Showed that depressive symptoms were associated with higher HOMA-IR values in middleaged women. The results were independent of participants' race but
were not statistically significant after adjustment for central adiposity.
In another population-based study of older adult males, HOMA-IR was associated with higher prevalent depressive symptoms and predicted incident depressive symptoms independently of clinical and demographic variables. 16 However, another study did not show a significant association between HOMA-IR and depressive symptoms. 17 Mexican-Americans show a high prevalence of cardio-metabolic disorders, as well as of depressive disorders. 4, 18 However, there is few information about the association between obesity, insulin resistance, and depressive symptoms among older Mexican-Americans.
The aim of this study is to investigate the association, and potential mediators, between obesity, insulin resistance, and depressive symptoms from a homogenous cohort of Mexican-Americans.
2 | METHODS
| Sample
This is a population-based study in which participants were recruited from randomly selected households and invited to participate in the Cameron County Hispanic Cohort (CCHC). 18 Households were randomly selected based on the 2000 census tract data in the city of Brownsville, Texas, situated on the US-Mexico border. All selected households were visited, and all occupants over the age of 18 years invited to participate. A total of 3778 subjects were enrolled at the baseline assessment. The mean age of the cohort at baseline assessment was 43.9 ± 16.6 years old. A total of 631 subjects were 60 years and older, and 500 completed the Center for Epidemiologic StudiesDepression (CES-D) scale for the assessment of depressive symptoms.
We included only those subjects with complete CES-D in the current analysis. There were no significant differences in sociodemographic characteristics between the subjects who were included vs excluded from the analysis.
This cohort is predominantly Mexican-American (>98%). Extensive family, socioeconomic, educational, and personal medical histories, as well as physical activity and dietary histories, were obtained using a directed questionnaire. Surveys and data collection were conducted in the participants' language of preference (Spanish or English) by bilingual research nurses and field workers.
| Measures
All clinical measures were taken during the study interview by trained research assistants using standardized research interview and questionnaires. Socioeconomic status/demographic characteristics:
Socioeconomic and demographic characteristics assessed included age (in years), gender, years of education, annual income, marital, and retirement status. 
Key points
• Depression is very common among older MexicanAmerican population.
• Cardiometabolic disorders are common comorbidities in depression, and these conditions may share common pathophysiological mechanisms.
• Our findings provide further support to the role of insulin resistance as a mechanism linking depression and cardiometabolic disorders in the elderly.
circumference in the analyses because it is a direct measure of central adiposity.
| RESULTS
The sociodemographic and clinical characteristics of this sample are shown in Table 1 To further explore the relationship between metabolic variables
and CES-D, we carried out additional mediational analyses. We used 
| DISCUSSION
To the best of our knowledge, this is the first study to investigate the association between insulin resistance, metabolic variables (ie, obesity, cholesterol levels), and depressive symptoms in older MexicanAmericans. We found that among metabolic variables, insulin resistance, central adiposity, and poor glycemic control are associated with depressive symptoms in older Mexican-Americans. Finally, insulin resistance fully mediates the association between central adiposity, glycemic control with depressive symptoms. Our results highlight the significant association between metabolic abnormalities and depressive symptoms in older Mexican-Americans and suggest that insulin resistance plays a pivotal role in this association. Nonetheless, we cannot exclude in our analysis the possible psychological impact of the diagnosis of diabetes, 8 as well as other biological factors that we did not evaluate in this current study, like inflammatory markers.
There are multiple mechanisms by which metabolic abnormalities are associated with depressive symptoms. First, metabolic abnormalities can lead to cerebrovascular disease and endothelial dysfunction which have been already linked to major depression in older adults. 11, 12, 23 Insulin resistance and metabolic abnormalities lead to the hyperactivation of GSK-3β that has been independently associated with major depression in older adults 24 and is also a target for the action of antidepressants. 25 Finally, mitochondrial dysfunction, increased oxidative stress, and epigenomic changes are common consequence of metabolic dysfunction and insulin resistance, and they are associated with emergence of depressive symptoms in young and older adults. 26 Therefore, by affecting different cellular and molecular functions, metabolic abnormalities, including insulin resistance and adverse lipid metabolism, can increase the risk of depressive symptoms in older adults.
Interventions that can improve insulin action can also lead, at least in part, to improvements in these conditions. Mild to moderate physical activity increases muscle insulin sensitivity and is a widely recommended intervention to improve glycemic control in patients with diabetes and to weight loss in obese individuals. Moreover, physical activity has also significant antidepressant effects, in particular in patients with mild depression. 27, 28 Metformin, a widely used glucose lowering agent that acts by increasing insulin sensitivity, has been shown to have mild antidepressant effect in diabetic patients. 29 Therefore, interventions aiming to reduce weight and to improve insulin resistance and glycemic control can ameliorate depressive symptomatology and should be considered in all depressed subjects.
The current study reports data from a homogeneous older MexicanAmerican population fromTexas, USA, 18 and may or may not be general- by the insulin and glucose levels, and insulin resistance is a core feature of diabetes. Finally, this was a cross-sectional study and therefore cannot establish causality between insulin resistance and depressive symptoms. Longitudinal studies are necessary to evaluate whether insulin resistance and other metabolic abnormalities increase the risk of depressive symptoms and whether interventions that reduce insulin resistance have antidepressant effects.
In conclusion, our results suggest that depressive symptoms are associated with central obesity and poor glucose control and that insulin resistance may play a role in this process. Additional studies, preferably randomized clinical trials or well-designed longitudinal observational studies, should be done to evaluate whether interventions that increase insulin sensitivity can also reduce depressive symptoms in this population regardless of central obesity or metabolic conditions.
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